Summary

• Page properties (1 modified, 0 added, 0 removed)

Details

Page properties

Content

...	...	@@ -16,8 +16,10 @@
16	16
17	17	Abbott in India develops and distributes over 600 products for healthcare professionals that promote health and well-being for Indians in all stages of life.{{footnote}}https://www.abbott.in/products/business-areas.pharmaceuticals-abbott-india-limited.html{{/footnote}}
18	18
19		-{{putFootnotes/}}
20	20
	20	+[[image:ABBOTINDIA.jpg]]
	21	+
	22	+
21	21	= Industry Overview =
22	22
23	23	The healthcare environment has been dynamic and, at times, volatile. As per IQVIA, a leading global provider of information and research services in the medical sector, Indian Pharmaceutical Market (IPM) is estimated at ` 149,900 Crore in 2020, its growth up by 2% from 2019. Acute therapies dominate IPM with 64% of the total sales; however, the chronic segment shows faster growth of 10.9% in comparison to 7.9% for acute therapies (3 year CAGR). The domestic pharmaceutical market is highly fragmented with the top 10 companies making up 43% of the share, and the top 150 companies accounting for 96% of share. Local players enjoy a dominant position, occupying 4 of the top 5 positions.{{footnote}}https://dam.abbott.com/en-ind/pdf/financials/2019-20-Annual-Report.pdf{{/footnote}}
...	...	@@ -86,6 +86,18 @@
86	86
87	87	**Other Expenses :** Other Expenses including Depreciation and Finance Cost increased by 7.8% over the last year. However as a percentage to Sales, it has decreased to 15.1% vis-à-vis 15.6% in the previous year
88	88
	91	+
	92	+**Abbott India Q3 net profit down 5% to Rs 177 crore **{{footnote}}https://www.moneycontrol.com/news/business/earnings/abbott-india-q3-net-profit-down-5-to-rs-177-crore-6479101.html{{/footnote}}
	93	+
	94	+**February 9, 2021**; Drug firm Abbott India on Tuesday reported a 5.11 percent decline in its net profit to Rs 177.14 crore for the quarter ended December.
	95	+
	96	+The company had posted a net profit of Rs 186.69 crore for the corresponding period of the previous fiscal, Abbott India said in a filing to BSE.
	97	+
	98	+The consolidated revenue from operations of the company stood at Rs 1,095.37 crore for the quarter under consideration.
	99	+
	100	+It was Rs 1,078.25 crore for the same period a year ago, it added.
	101	+
	102	+
89	89	= References =
90	90
91	91	{{putFootnotes/}}